PUBLICATIONS

Our research advances computational structural biology, AI-driven drug discovery, and molecular modelling, with contributions published in leading Q1 journals across multiple disciplines.

The Irina Moreira Lab’s publications reflect our interdisciplinary approach, spanning GPCR signalling, viral protein interactions, rare disease mechanisms, and predictive toxicology. Our work combines physics-based simulations, machine learning frameworks, and large-scale cheminformatics to deliver mechanistic insights and translational tools.

Interested in our research or potential collaborations?


2025

  • 83. Amorim AMB, Marques-Pereira C, Almeida T, Rosรกrio-Ferreira N, Pinto HS, Vaz C, Franciso A, Moreira IS, ViralBindPredict: Empowering Viral Protein-Ligand Binding Sites through Deep Learning and Protein Sequence-Derived Insights, 2026, GigaScience. IF 3.9, Q1, JIF Percentile 81.50.
  • 82. Amorim AMB, Orzel U, Caniceiro AB, Rosรกrio-Ferreira N, Moreira IS, How Artificial Intelligence is Changing the Game for Rare Diseases: From Screening to Treatment, Trends In Pharamcological Sciences, 2025. IF 19.9, Q1, JIF Percentile 99.10.
  • 81. Lourinho A, Silva M, Tahiri E, Pinto A, Caniceiro B, Moreira IS, Duarte CB, Costa RO, RNAarchitecs: how hnRNPs shape neuronal landscapes, Brain, awaf448. IF 11.7, Q1, JIF Percentile 98.20.
  • 80. Portugal CC, Almeida TO, Tedim-Moreira J, Silva C, Canedo T, Galvรฃo J, Magalhรฃes A, Summavielle T, Fassier R, Bai X, Kirchhoff F, Moreira IS, Pinto IM, Costa J, Guedes J, Peรงa J, Socodato R, Relvas JB, Disrupting the microglial cytoskeleton accelerates senescence and causes premature synaptic aging, 2025; Journal of Neuroinflamation, 2025, 22, 264. IF 10.1, Q1, JIF Percentile 95.90.
  • 79. Caniceiro A, Amorim AMB, Rosรกrio-Ferreira N, Moreira IS, GPCR-A17 MAAP: Mapping modulators, agonists, and antagonists to Predict the Next Bioactive Target, J. Cheminformatics, 2025, 17, 102. IF 5.7, Q1, JIF Percentile 85.40.
  • 78. Orzel U, Barreto CAV, Filipek S, Moreira IS, GPCR Oligomerization Across Classes: A2AR-Mediated Regulation of mGlu5R Activation, Int J Biol Macromol, 2025. IF 8.5, Q1, JIF Percentile 93.60.

2024

  • 77. Gouveia RP, Barreto C, Melo R, Carvalho AL, Moreira IS, Exploring the Impact of V143L Mutation on the Dynamic Interaction between Stargazin and GluA2, Front. Cell. Neurosci. 2024, 18. IF 4.9, Q2, JIF Percentile 74.80.
  • 76. Barreto CAV, Moreira IS, An atomic look at the interface of GHSR and its partners, Comput Struct Biotech J, 2024, 23, 4242-4251. IF 5.2, Q2, JIF Percentile 67.40.
  • 75. Barreto CAV, Vitorino JNM, Reis PBPS, Machuqueiro M, Moreira IS, pKa calculations of GPCRs: understanding protonation states in receptor activation, J. Chem. Inf. Model. 2024, 17, 6850-6856. IF 5.3, Q1, JIF Percentile 82.20.
  • 74. Novo JP, Gee L, Caetano AC, Tomรฉ I, Vilaรงa A, Zglinicki T, Moreira IS, Jurk D, Rosa S, Ferreira L, Blood-brain barrier dysfunction in ageing is mediated by brain endothelial senescence, Aging Cell, 2024. IF 7.1, Q1, JIF Percentile 93.20.
  • 73. Amorim AM, Piochi LF, Gaspar AT, Preto AJ, Rosรกrio_Ferreira N, Moreira IS, Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction, Chem. Res. Toxicol. 2024, 37, 6, 827-849. IF 3.8, Q2, JIF Percentile 73.60.
  • 72. Preto AJ, Caniceiro AB, Duarte F, Fernandes H, Ferreira L, Mourรฃo J, Moreira IS, POSEIDON: Peptidic Objects SEquence-based Interaction with cellular DOmaiNs, J Cheminform, 2024, 16, 18  IF 5.7, Q1, JIF Percentile 85.40.
  • 71. Lin Y-C, Swendeman S, Moreira IS, Ghosh A, Kuo A, Rosรกrio-Ferreira N, Guo S, Culbertson A, Levesque M, Cartier A, Seno T, Schmaier A, Galvani S, Inoue A, Parikh S, FitzGerald GA, Zurakowski D, Liao M, Flaumenhaft R, GรผmรผลŸ ZH, Hla T, Designer high-density lipoprotein particles enhance endothelial 1 barrier function and suppress inflammation, 2024, Science Signalling โ€“ In press. IF 7.3, Q1, JIF Percentile 86.51.

2023


2022


2021


2020


2019


2018


2017


2016


2015


2014


2013


2012


2010


2009


2008


2007


2006


2005


2003

  • 1. Fernandes PA, Carvalho ATP, Marques AT, Pereira ALF, Madeira APS, Ribeiro ASP, Carvalho AFR, Ricardo ETA, Pinto FJV, Santos Hร, Mangericao HDG, Martins HM, Santos HRR, Moreira IS, Azeredo MJV, Abreu RPS, Oliveira RMS, Sousa SFM, Silva RJAM, Mourรฃo ZS, Ramos MJ, New designs for MRI contrast agents, J. Comp. Aided Mol. Design, 2003, 17: 463-473. IF 2.4, Q2, JIF Percentile 59.85.

BOOK CHAPTERS


2022


2021


2020


2019


2018


2017


2012


2010


2008

  • 2. Moreira IS, Fernandes PA, Computational Alanine Scanning Mutagenesis in Computational Proteomics, ed Maria J. Ramos, Transworld Research Network, 2008, 81-100.

2007


CONFERENCE PROCEEDINGS


2023


2019


2017


2016


2015


2014


2013


2010